News | July 22, 2024
dsm-firmenich to sell MEG-3 fish oil business to KD Pharma Group
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
The academy has secured partnerships with 15 esteemed hospitals
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
Subscribe To Our Newsletter & Stay Updated
